We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
5 hedge funds and large institutions have $198K invested in Windtree Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more capital invested
Capital invested by funds: $152K → $198K (+$46K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
17% less funds holding
Funds holding: 6 → 5 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$168K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$51K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.76K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.32K |